Chronic postoperative pain is common and can have a negative impact on quality of life. Recent studies show that genetic risk factors are likely to play a role, although only gene-targeted analysis has been used to date. This is the first genome-wide association study to identify single-nucleotide polymorphisms associated with the development of chronic postoperative pain based on two independent cohorts. In a discovery cohort, 330 women scheduled for hysterectomy were genotyped. A case-control association analysis compared patients without chronic postoperative pain and the 34 who had severe chronic postoperative pain 3 months after surgery. No single-nucleotide polymorphisms reached genome-wide significance, but several showed suggestive associations with chronic postoperative pain (p < 1 9 10 À5 ). Single-nucleotide polymorphisms with significance p < 1 9 10 À5 were followed up in a replication cohort consisting of 203 men and women scheduled for orthopaedic or abdominal surgery. Ten of these patients developed severe chronic postoperative pain. A single-nucleotide polymorphism in NAV3 was significantly replicated with chronic postoperative pain in the replication cohort (p = 0.009). Meta-analysis revealed that two loci (IQGAP1 and CRTC3) were significantly associated with chronic postoperative pain at 3 months (IQGAP1 p = 3.93 9 10 À6 b = 2.3863, CRTC3 p = 2.26 9 10 À6 , b = 2.4209). The present genome-wide association study provides initial evidence for genetic risk factors of chronic postoperative pain and supports follow-up studies.
Introduction
Moderate to severe chronic postoperative pain is a debilitating condition affecting between 5% and 85% of patients undergoing surgery and has a large negative impact on the quality of life (QoL) and socio-economic status [1] [2] [3] . It is defined as "pain developed or increased after a surgical procedure, which is present for at least three months, and affecting the QoL" [4, 5] . Furthermore, the pain is localised to the surgical field or projected innervation area of a nerve and other causes for the pain must have been excluded [4, 6] . Both clinical (e.g. type of surgery) and baseline characteristic (e.g. psychosocial status) risk factors have been described but these do not explain all the observed variance. So far, a good understanding of genetic risk factors for chronic postoperative pain is still lacking [1, 7] .
The underlying biology of chronic postoperative pain and genetic heritability is complex and not yet fully understood [8] . However, twin studies in pelvic and low back pain have indicated the importance of genetics in chronic pain phenotypes with an estimated heritability of 40% [9, 10] . Association studies focusing on candidate genes have suggested a possible role for COMT, GCH1, and KCNS1 among others [11] [12] [13] , but a recent systematic review showed conflicting results for all the genes tested [14] . We tried to identify genetic polymorphisms in the human genome associated with chronic postoperative pain 3 months after surgery by performing a genome-wide association study using a unique discovery cohort of patients undergoing hysterectomy [15] . The advantage of this cohort is the homogenous population consisting of only women (age 18-65, malignancies excluded) [16, 17] .
Potential candidates were then further explored in a replication cohort of orthopaedic and abdominal surgeries to verify our findings. Combining different clinical cohorts allows testing for different genetic risk factors associated with chronic postoperative pain in general and each individual cohort gives information on surgery-specific risk factors, as shown before in migraine research [18] . A metaanalysis of the discovery and the replication cohort was conducted to investigate the combined effects of both studies.
Methods
This study was approved by our local Medical Ethical Committee (both discovery and replication study) and all participants gave written informed consent.
An elaborate description of recruitment and data collection protocols for the discovery cohort has been published elsewhere [15] . In brief, a multicentre prospective cohort study was conducted, recruiting patients from four hospitals in the Netherlands. Patients undergoing hysterectomy for benign indications between September 2010 and January 2014 were included in the study.
Inclusion criteria were: age between 18 and 65 y; fluency in the Dutch language; elective surgery; and total or subtotal hysterectomy with or without oophorectomy using all types of surgical approach. Exclusion criteria consisted of: illiteracy; history of cancer; and cognitive impairment. For the replication study, two multicentre prospective cohort studies were conducted recruiting patients from three hospitals in Italy. In both studies, peripheral blood samples were collected during surgery and genomic DNA was isolated. Inclusion criteria of the orthopaedic cohort consisted of adult patients of all sexes undergoing total knee arthroplasty with ASA physical status 1-3. All patients enrolled had the same regional anaesthesia procedure in order to reduce any bias related to anaesthesia treatment and difference in intra-operative pain. Patients were excluded if there were contra-indications to regional anaesthesia, unstable neurological diseases, diabetes or pre-surgical pain and if regional anaesthesia block was not effective.
The protocol of the abdominal surgery trial has been already published [19] . Inclusion of the abdominal surgery cohort comprised adult patients of all sexes scheduled for major abdominal or urological surgery without regional anaesthesia, ASA physical status 1-3 and HIV negative. COMT and OPRM1) [20] [21] [22] . Psychological predictors are an important risk factor for chronic postoperative pain [15, 23, 24] . We believe this approach offers greater potential to identify genetic variants with phenotypic effects in chronic postoperative pain. The array includes 265,000 proven tag single-nucleotide polymorphisms (SNPs) found on the Infinium Core-24 Bead Chip, 245,000 markers from the Infinium Exome-24 Bead Chip and 50,000 additional markers associated with common psychiatric disorders.
Genotypes were called using BeadStudio (Genome The primary outcome measured in this cohort was the highest surgery-related pain score at rest during the last week at 3 months after surgery measured by the numeric rating scale (NRS) [15] . Based on the primary outcome measure, patients were divided into a non-pain (NRS = 0) and a chronic postoperative pain (NRS > 3) group to perform an extreme phenotype analysis to increase the power. Patients with mild pain (NRS between 1 and 3) score were not included in the genetic analysis. The gene dosages were tested for an association with chronic postoperative pain using an additive logistic regression model. To decrease false-positives, the maximum threshold of k was set at 1.08 [32] . Genome-wide significance was set at p < 5 9 10 À8 and the analysis was run using SNPTEST (https://mathgen.stats.ox.ac.uk/genetics_software/snptest/ snptest.html, v2.5.4, Oxford University, Oxford, UK) [32, 33] .
Single-nucleotide polymorphisms with a p value < 1 9 10 À5 were selected as suggestive association SNPs for replication [34] . The same statistical tests were used for the discovery and the replication cohort. Next, the discovery and the replication cohort's association SNP results were used to perform a random-effects meta-analysis in Plink. As the study design of the two cohorts was different, and some covariates (e.g. age) differed significantly between the cohorts, we chose to perform a random-effects metaanalysis. Bonferroni correction was applied to account for multiple testing.
Power calculation for this study was redundant conducted and based on the primary aim of the study and not for the genetic testing, which was a secondary aim. Therefore, this study is underpowered for a genome-wide analysis study and, as a consequence, there is a risk of a type-1 error which should be taken into account when interpreting the results [15] .
Results Figure 1 shows the flow chart for inclusion, follow-up and genetic quality control, which is an extended version of the flow chart of our previous publication [15] . Ethnicity of both cohorts was checked using the HapMap data and was determined to be of European background (Fig. 2 ). Subjects deviating from this background were not analysed during quality control (discovery cohorts n = 12, replication cohort n = 4).
After quality control and imputation, 6,293,655 SNPs were included analysis. Overall association results are depicted in Fig. 3a . The QQ plot showed no apparent deviation from the null distribution of p values ( Fig. 3b ) and the genomic inflation factor (Fig. 3b , k GC = 1.065) indicated only a slight inflation of the model without covariates.
Although none of the SNPs tested reached the threshold for genome-wide significance (p < 5 9 10 À8 , Fig 3a) , several reached a suggestive level of association (107 SNPs with p < 1 9 10 À5 , Fig 3a) which were further analysed and labelled as 'SNPs of interest'. Results of the top loci are shown in Table 2 and all SNPs were annotated using GRCh37.p13. A SNP cluster tagged by rs62281806 in FNDC3B was the most significant hit (p = 5.59 9 10 À7 ).
Other genes tagged by SNPs included EDNRA, NAV3, TLL2, RSU1, IQGAP1, TMEM63B, PJA2, CRTC3 and DLG2. None of these genes have been associated with chronic postoperative pain before, according to a recent systematic review [14] . The detailed results of the discovery cohort (SNPs p < 0.05) are available on request from the correspondence author.
In the discovery cohort, no SNP reached the threshold for genome-wide significance. We decided to replicate only those SNPs in the replication cohort which showed a suggestive association (p < 1 9 10 À5 ) with the phenotype to increase the power [34] . The SNPs (n = 107) showing suggestive association in the discovery cohort were further evaluated in an independent replication cohort. Results of the top replication loci are shown in Table 2 and the complete results in the Supporting Information Table S1 .
The SNP (rs118184265) in NAV3 showed nominal significance (p < 0.01) with chronic postoperative pain at 3 months and two SNPs within RSU1 (rs7894047, rs7893777) showed a trend towards statistical significance (p = 0.068). As the number of patients was limited, we decided to increase the cases by including all women with mild pain at 3 months (NRS > 0). The NAV3 SNP remained significant although somewhat decreased (p = 0.014) and
the RSU1 SNPs became significant (p = 0.049) (see also
Supporting Information Table S2 ). The direction of the effect in the replication study is reversed compared with the discovery cohort.
The SNPs studied in both the discovery and the replication cohort (n = 96) were analysed in a randomeffects meta-analysis to see the overall effects. Results of the top loci are shown in Table 2 and the complete results in the Supporting Information Table S3 . The most significant SNP was rs117119665 in CRTC3 (p = 2.26 À6 , b = 2.4209, adjusted p = 2.41 À4 ). The second significant SNP was rs1145324 in IQGAP1 (p = 3.93 À6 , b = 2.3863, adjusted e114 p = 4.20 À4 ). Several nominally significant associations were found (rs11655475 and rs4790802, p < 0.05) but these were not annotated to a gene.
Both significant SNPs are located closely together on chromosome 15 within a region of low recombination ( Fig. 4) . To test whether the two SNPs (rs117119665 and rs1145324) are independent or part of the same locus, we performed a conditional analysis of each SNP with the other SNP as covariate. This analysis showed that the association with chronic postoperative pain disappeared (p > 0.1) and, thus, the SNPs are not independent. There is a possible involvement of rs4347600 in CRTC3 as well but this SNP was not tested in the replication cohort and could, therefore, not be entered into the meta-analysis ( Fig. 4 ).
Discussion
One locus (NAV3) of the SNPs of interest was associated with chronic postoperative pain in the replication cohort.
Two loci (CRTC3 and IQGAP1) were significantly associated with chronic postoperative pain in the meta-analysis of the discovery and replication cohort. Unfortunately, the sample size of the discovery cohort was too small and, thus, the study was underpowered. The replication cohort and metaanalysis partially overcome this problem but results should be interpreted cautiously. Nevertheless, the study provides an initial insight to genome-wide risk factors of chronic postoperative pain.
The meta-analysis indicated two genes (CRTC3 and IQGAP1) as risk loci for the development of chronic postoperative pain. However, neither has been associated with pain before according to the PainGenesDatabase and the Human Pain Genetics Database [22, 35] . CREB-regulated transcription co-activator 3 (CRTC3) is expressed in a variety of tissues including the nervous system, is involved in regulation of CREB-dependent transcription of genes and inhibits adenylyl cyclase in response to catecholamine signalling [36, 37] . It has been associated with several abdominal disorders such as Crohn's and inflammatory bowel disease and cognitive information processing [38] [39] [40] .
IQ motif containing GTPase-activating protein 1 (IQGAP1) is expressed throughout the body including the nervous system, and is involved in cytoskeleton regulation, signalling molecules and cell motility [36] . It has been associated with immune system functioning and multiple sclerosis [41, 42] .
Interestingly, two genome-wide association studies found both CRTC3 and IQGAP1 associated with their primary outcome measure (heel bone mineral density and neutrophil percentage of white cells, respectively) indicating a possible synergism or interaction between the two genes [42, 43] . In our study, the SNPs in both genes are in linkage disequilibrium with each other and influence the development of chronic postoperative pain together. Their involvement in the immune system is supportive of postoperative infection being a risk factor for the development of chronic postoperative pain, as previously shown [15] .
In addition, a significant association of a SNP in NAV3
(neuron navigator 3) with chronic postoperative pain was noted in the replication cohort, which was part of the SNPs of interest in the discovery cohort. NAV3 is a gene predominantly expressed within the central and peripheral nervous systems, is involved in axonal growth and is upregulated 24 h after brain injury [44] . Another SNP in NAV3, found to be upregulated in degenerating Alzheimer's disease [45] , has been associated with brain development and neuronal differentiation [46] . Interestingly, the NAV3 gene has been associated with complex regional pain syndrome [47] . However, the direction of the effect of NAV3 differed between the discovery (protective effect) and
replication cohort (risk effect) which could be due to several reasons. One of these could be that the effect of SNPs is subtype specific as already shown in migraine [18] . The replication cohort consisted of a variety of surgeries, while the discovery cohort was focused on hysterectomy, although the hysterectomy approach did differ slightly between hospitals. Genetic studies and GWAS in particular, face several difficulties in the field of chronic postoperative pain. The first challenge is unifying the phenotype and the subphenotypes of chronic postoperative pain [3] . Several efforts have been pain with detailed symptoms per subphenotype [3] .
Migraine research has done this subclassification before and a recent genome-wide assocaition meta-analysis identified subtype-specific risk loci, which is a good example of the direction the field should pursue [18] . Our study provides a foundation for follow-up genomewide association studies on chronic postoperative pain. Our Table 2 Association results of the top genomic loci with suggestive genome-wide association in the discovery cohort (p < 1 9 10 À5 ). Women have a higher chance of developing chronic postoperative pain than men [48, 49] . To overcome this difference, we decided to analyse only the women in the cohort who did not undergo methylprednisolone infusion.
SNP and gene information
Secondly, there was a significant 20-year mean age difference between the discovery and the replication cohorts. Younger age is a risk factor for chronic postoperative pain and should be corrected for where possible [48] . To correct for age, a random-effects instead of a fixed effects meta-analysis was conducted as the study design and influential covariates differed between studies.
Currently, a significant portion of the variance in the risk of developing chronic postoperative pain remains to be elucidated, despite the already comprehensively studied psychological, clinical and baseline characteristic risk factors [1, 17, 23] . The identification of genetic risk factors will be a key step towards identifying people at risk of chronic postoperative pain and devising new treatment strategies based on optimised prediction modelling.
Although this genome-wide association study alone did not yield genome-wide significant SNPs, the meta-analysis 
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